Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIngenta Regulatory News (ING)

Share Price Information for Ingenta (ING)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 148.50
Bid: 147.00
Ask: 150.00
Change: 0.00 (0.00%)
Spread: 3.00 (2.041%)
Open: 148.50
High: 148.50
Low: 148.50
Prev. Close: 148.50
ING Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and Contract W

26 Jun 2008 07:00

RNS Number : 5661X
Publishing Technology PLC
26 June 2008
 



Publishing Technology PLC ("Publishing Technology" or "the Company")

Contract win and trading update

Publishing Technology which provides targeted software and consulting solutions for publishers and information providers is pleased to announce that Washington DC based BioOne, has selected the PCG division of Publishing Technology PLC to provide its content sales representation. BioOne who provide a unique aggregation of high-impact bioscience research journals, have seen a consistently large increase in sales since its inception eight years ago, have selected PCG because they believe that PCG can provide the impetus to continue the growth.

The three year agreement will represent a 50% increase in revenues (approx £500,000 net) for the PCG division of Publishing Technology in 2009, with sales starting in quarter three of 2008.

Trading update

The Board of Publishing Technology believes that contract gains such as BioOne underline the achievements of the group since its inception in 2007. In 2008, the group has concentrated on increasing revenues whilst rationalising costs, and focusing on higher margin activities, and the Board is pleased to report positive progress on all fronts. Revenues have increased quarter on quarter and overheads reduced, whilst, with the addition of the BioOne contract, recurring revenues are now expected to exceed 65% of total revenues for the group. Cross-selling of the range of products and services within our established customer base has exceeded forecasts, and the order book for the remainder of the year is healthy with a high level of signed business. 

The Board is seeing no discernable slow down in market activity, and believes this is because Publishing Technology provides the means for publishers and information providers to increase their revenues, whilst rationalising their costs.

The Board intends to continue to pursue organic growth and increased profits and, where appropriate, earning enhancing acquisition opportunities. A further update will be given at the time of the interim results in August 2008.

George Lossius, CEO of Publishing Technology commented:

"This represents a significant advance for the PCG division which has shown significant growth in the last couple of years, and this contract will support the group as it targets growth and increased profits. BioOne is a highly respected source of bioscience research materials, and we are delighted to be given this opportunity to represent BioOne and its team. " 

Martyn Rose, Chairman commented

"I am delighted with the progress Publishing Technology has made since its inception, and feel more confident now than at any time that the merger of last year was the right thing for us, our investors and customers, and I would like to thank them for their support during this time."

For further information please contact:

Publishing Technology PLC

George Lossius/Alan Moug 01865 397800

FinnCap, nominated adviser

Geoff Nash/Rose Herbert 020 7600 1658

The Communication Group plc 

Richard Evans  020 7630 1411 / 0775 108 7291

Kit Bingham 020 7630 1411 / 0788 074 8672

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUVVRRWORNUUR
Date   Source Headline
31st Jan 20247:00 amRNSTrading Update
25th Oct 20233:57 pmRNSChange of Nomad and Broker
17th Oct 20235:41 pmRNSHolding(s) in Company
28th Sep 20237:00 amRNSNew customer wins
11th Sep 20237:00 amRNSHalf-year Report
8th Sep 20232:44 pmRNSInvestor Presentation via Investor Meet Company
31st Jul 20237:00 amRNSTrading Update
29th Jun 202312:52 pmRNSResult of AGM & Dividend Timetable
29th Jun 20237:00 amRNSAGM statement and contract wins
25th May 20234:00 pmRNSPosting of Annual Report & Notice of AGM
17th May 20237:00 amRNSInvestor Presentation via Investor Meet Company
11th May 20237:00 amRNSFinal Results
28th Apr 20237:00 amRNSNotice of Final Results
2nd Feb 20237:00 amRNSTrading Update
2nd Dec 20226:02 pmRNSDirector/PDMR Shareholding
16th Nov 20224:31 pmRNSHolding(s) in Company
14th Nov 20223:57 pmRNSResult of Tender Offer
11th Nov 202211:24 amRNSResult of General Meeting
25th Oct 20227:00 amRNSProposed Tender Offer & Notice of General Meeting
21st Sep 20227:00 amRNSHalf-year Report
13th Sep 20227:00 amRNSNotice of Interim Results & Investor Presentation
3rd Aug 20222:09 pmRNSHolding(s) in Company
1st Aug 20227:00 amRNSTrading Update
28th Jul 20223:02 pmRNSResult of AGM and Dividend Timetable
8th Jul 20227:00 amRNSGrant of Options
29th Jun 202211:09 amRNSPosting of Annual Report and Notice of AGM
27th Jun 20227:00 amRNSFinal Results
17th Jun 202212:27 pmRNSChange of Registered Office
29th Apr 20227:00 amRNSChange of Final Results Date
31st Jan 20227:00 amRNSDirector/PDMR Shareholding
26th Jan 20227:00 amRNSTrading Update
20th Sep 20217:01 amRNSDividend Declaration
20th Sep 20217:00 amRNSHalf-year Report
15th Sep 20215:22 pmRNSNotice of Results and Investor Presentation
20th Jul 20214:34 pmRNSTransaction in Own Shares and TVR
19th Jul 202111:54 amRNSHolding(s) in Company
15th Jul 20214:40 pmRNSTransaction in Own Shares and TVR
2nd Jul 20214:52 pmRNSTransaction in Own Shares and TVR
2nd Jul 20214:49 pmRNSDividend Timetable
30th Jun 20214:51 pmRNSDirector/PDMR Shareholding
30th Jun 20214:47 pmRNSTotal Voting Rights
30th Jun 20214:10 pmRNSResult of AGM
25th Jun 202110:54 amRNSHolding(s) in Company
18th Jun 20215:03 pmRNSTransaction in Own Shares and TVR
4th Jun 20219:52 amRNSDirectorate Change
4th Jun 20219:48 amRNSPosting - Annual Report & Accounts & Notice of AGM
1st Jun 20217:00 amRNSFinal Results
24th Feb 20214:47 pmRNSTransaction in Own Shares and TVR
24th Feb 20217:00 amRNSTransaction in Own Shares and TVR
23rd Feb 20217:00 amRNSTransaction in own Shares and TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.